Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
Submitted by
admin
on March 3, 2014 - 11:55am
Source:
TheStreet.com
News Tags:
glioblastoma multiforme
DCVax
Northwest Biotherapeutics
ICT-107
ImmunoCellular Therapeutics
Headline:
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
Do Not Allow Advertisers to Use My Personal information
